Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
37 Cards in this Set
- Front
- Back
what processes lead to portal HTN
|
1. increased resistance leading to increased sinusoidal pressure due to deposition of collagen
2. endothelial cell dysfunction resulting in decreased NO production and increased endothelin-1 production 3. vasodilation of splanchnic arterioles secondary to increased NO production increased blood flow through portal system and decreases effective intravascular volume which activates RAAS |
|
what deposits ECM resulting in increased resistance blood flow through the liver
|
stellate-derived myofibroblasts
|
|
differentiate intrahepatic portal vein obstruction from prehepatic portal vein obstruction on physical exam
|
intrahepatic will show caput medusa on exam while prehepatic will not
|
|
3 physical exam findings that indicate the presence of portal HTN
|
splenomegaly
caput medusa jaundice |
|
why does ascites develop intrahepatic and posthepatic but no prehepatic portal HTN
|
ascites develops due to increased sinusoidal pressure and allow fluid and protein to leak into the peritoneal cavity, prehepatic does not lead to increased sinusoidal pressure
|
|
what is hepatic wedge pressure (HVPG)
|
measures the difference between the portal vein pressure and the SVC pressure
*normal is 3-5 mmHg |
|
in what two situations will HVPG be increased
|
cirrhosis - intrahepatic sinusoidal blockade
radiation therapy - post-sinusoidal blockade |
|
in what situations (and cause) will HVPG be normal in the presence of portal HTN
|
pre-sinusoidal - schistosomiasis
pre-hepatic - portal vein thrombosis post-hepatic - Budd-Chiari syndrome |
|
what histilogic features of hepatic sinusoids differentiate them from other capillary beds
|
contain fenestrae and lack a BM so they are more permeable to protein
|
|
calculate SAAG
|
(serum albumin concentration) - (ascetic albumin concentration)
|
|
differentiate a SAAG of greater than or less than 1.1 mg/dL
|
SAAG > 1.1 mg/dL seen in portal HTN (transudative)
SAAG < 1.1 mg/dL seen in peritoneal malignancy or infection (exudative) |
|
differentiate between sinusoidal portal HTN seen in cirrhosis from post-sinusoidal portal HTN because both have a SAAG of > 1.1 mg/dL
|
cirrhosis (sinusoidal) - ascitic albumin is < 2.5 mg/dL
RHF or veno-occlusive disease (post-sinusoidal) - ascitic albumin is > 2.5 mg/dL |
|
why does cirrhosis have less ascitic albumin than that found in RHF or veno-occlusive disease
|
between the ECM accumulation caused by stellate-derived myofibroblasts cause less protein to be able to traverse the hepatic sinusoids
|
|
what causes hepatic encphalopathy
|
accumulation of toxins in the CNS due to impaired urea cycle leading to increased systemic levels of NH3
|
|
what causes astrocytic dysfunction and proliferation leading to Alzheimer type II astrocytosis
|
build of NH3 causes the astrocytes to convert it to glutamine, this is the only mechanism in the CNS to clear ammonia
|
|
how does ammonia accumulation lead to decreased excitatory neurotransmission (3)
|
1. neurons are unable to convert glutamine to glutamate due to excessive NH3
2.increased GABA production by intestinal bacteria which bypasses the liver 3. increased aromatic AA serve as precursors for false excitatory neurotransmitters and cause depletion of true ones |
|
what causes asterixis
|
neuroinhibition due to increased GABA and decreased glutamate, NE, and E
|
|
how do the following precipitate hepatic encephalopathy: hypokalemia, metabolic alkalosis, GI bleeding, high protein diet, constipation, and infection
|
hypokalemia - stimulates renal PCT to increase NH4 synthesis as well as stimulating development of metabolic alkalosis
metabolic alkalosis - increases conversion of NH4 --> NH3 GI bleeding - increased substrate for NH3 production high protein diet - increases NH3 production constipation - increase production of NH3 by bacteria infection - increases tissue catabolism |
|
what test is useful for predicting the severity of acute liver injury
|
PT - increased PT indicates that the vitamin K dependent clotting factors are not being made
|
|
hemodynamid findings seen in chronic liver failure
|
low systemic vascular resistance (AV shunting)
high CO increased HR |
|
what two things cause low SVR in patients with chronic liver failure
|
NO and substance P - causes AV shunting
|
|
what is the mechanism of hepatorenal syndrome
|
renal vasoconstriction of afferent arteriole secondary to sympathetic nervous system responding to decreased vascular resistance and decreased PGE2 production
|
|
expected serum findings in hepatorenal syndrome
|
hypervolemic hyponatremia - due to stimulation of vasopressin secondary to decreased effective intravascular volume
increased creatinine > 1.5 mg/dL |
|
what is orthodeoxia
|
deoxygenation in the upright position
|
|
what is the mechanism behind orthodeoxia
|
1. intrapulmonary shunts due to increased pulmonary vascular angiogenesis
2. decreased time for O2 to diffuse 3. increased distance between the RBC and alveolus from vasodilation |
|
what are the characteristic blood findings in hepatopulmonary syndrome
|
increased (A-a)O2 gradient
PaO2 < 70 mmHg PaCO2 30-35 mmHg |
|
which gonadal hormone is increased in men with liver failure
|
estrogen due to increased peripheral conversion of androgens to estrogen
|
|
which gonadal hormone is decreased in women with liver failure
|
progesterone
|
|
why do patients with cirrhosis and ascites develop hyperglycemia
|
seen postprandally due to decreased glucose utilization in muscle and decreased glucose extraction
|
|
why do patients with end-stage parenchymal failure develop hypoglycemia
|
hepatic glycogen depletion and decreased gluconeogenesis
|
|
two acid-base abnormalities that commonly develop in chronic liver failure
|
anion-gap metabolic acidosis - build up of lactate due to AV shunting
respiratory alkalosis - CNS stimulation because of mild hypoxemia |
|
at what pressure does portal HTN exist
|
portal pressure > 12 mmHg
|
|
what is a predisposing factor for developing spontaneous bacterial peritonitis
|
large volume of ascites with low albumin content (<1.5 g/dL)
|
|
patient with ascites presents with fever, abdominal pain, worsening encephalopathy and > 250 PMNs in ascitic fluid
|
bacterial peritonitis
|
|
serum cholesterol in hepatic failure
|
decreased due to decreased hepatic synthesis along with decreased intestinal absorption
|
|
manifestations of systemic vascular dilation that occur in areas drained by the SVC
|
spider telangectasias
|
|
ethanol abuse and effects on phase I and II hepatic enzymes
|
increases phase I leading to conversion of benign medications to more toxic intermediates
decrease phase II resulting from glutathion deficiency *increased phase I and decreased phase II make it difficult to handle drugs like acetaminophen |